Immunosuppressive therapy of autoimmune hypoparathyroidism in a patient with activating autoantibodies against the calcium-sensing receptor.

Mina ChamberlinElizabeth Helen KempAnthony P WeetmanBhupesh KhadkaEdward M Brown

Published in: Clinical endocrinology (2018)

This is the first demonstration of CaSR antibody-mediated hypoparathyroidism responsive to immunosuppressive therapy, adding to the evidence that autoimmune hypoparathyroidism can be, in some cases, reversible and not the result of autoimmune parathyroid destruction.

Keyphrases

multiple sclerosis
drug induced
systemic lupus erythematosus
signaling pathway
case report
stem cells
mesenchymal stem cells
binding protein